Business Description
Abnova (Taiwan) Corp
ISIN : TW0004133004
Total Employee Number:
190Description
Abnova (Taiwan) Corp is engaged in developing, manufacturing, and selling monoclonal antibody, polyclonal antibody, proteins, medical inspection instruments and testing reagents, which are mainly antibody reagents, antibody chips or related products provided to and used by academic, research institutions or pharmaceutical factories. Geographically, it operates in America, Europe, Taiwan and Other Countries. It generates maximum revenue from America. Its products include: SARS-CoV/CoV-2, DNA, RNA new, Proteins/peptides, MaxPab, DNAxPab, Polyclonal Ab, Monoclonal Ab and Others. The company's services are: Gene synthesis & cytogenetics, Peptide services, Protein expression, Humanized antibody, Assay development, Conjugation, FFPE tumor tissue DNA, In situ hybridization (ISH) and Others.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 20.42 | |||||
Equity-to-Asset | 0.95 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | 0.69 | |||||
Interest Coverage | 41.2 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 11.82 | |||||
Beneish M-Score | -2.27 | |||||
WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -5.1 | |||||
3-Year EBITDA Growth Rate | -40.7 | |||||
3-Year Book Growth Rate | -0.9 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 74.61 | |||||
9-Day RSI | 62.97 | |||||
14-Day RSI | 56.32 | |||||
3-1 Month Momentum % | -6.36 | |||||
6-1 Month Momentum % | -4.47 | |||||
12-1 Month Momentum % | -20.34 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 17.02 | |||||
Quick Ratio | 8.3 | |||||
Cash Ratio | 7.02 | |||||
Days Inventory | 858.63 | |||||
Days Sales Outstanding | 49.61 | |||||
Days Payable | 29.69 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.54 | |||||
3-Year Dividend Growth Rate | 25.1 | |||||
Forward Dividend Yield % | 0.54 | |||||
5-Year Yield-on-Cost % | 3.04 | |||||
Shareholder Yield % | -0.26 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 44.35 | |||||
Operating Margin % | 4.97 | |||||
Net Margin % | -0.33 | |||||
EBITDA Margin % | 7.69 | |||||
FCF Margin % | -2.85 | |||||
OCF Margin % | -1.19 | |||||
ROE % | -0.09 | |||||
ROA % | -0.08 | |||||
ROIC % | 1.11 | |||||
3-Year ROIIC % | 103.22 | |||||
ROC (Joel Greenblatt) % | -0.22 | |||||
ROCE % | -0.13 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shiller PE Ratio | 26 | |||||
PS Ratio | 3.66 | |||||
PB Ratio | 1.02 | |||||
Price-to-Tangible-Book | 1.07 | |||||
EV-to-EBIT | -575.95 | |||||
EV-to-EBITDA | 34.22 | |||||
EV-to-Revenue | 2.63 | |||||
EV-to-FCF | -90.09 | |||||
Price-to-GF-Value | 0.75 | |||||
Price-to-Projected-FCF | 0.79 | |||||
Price-to-Median-PS-Value | 0.75 | |||||
| Price-to-Net-Current-Asset-Value | 1.52 | |||||
| Price-to-Net-Cash | 4.18 | |||||
Earnings Yield (Greenblatt) % | -0.18 | |||||
FCF Yield % | -0.78 | |||||
Forward Rate of Return (Yacktman) % | -10.66 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Abnova (Taiwan) Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 351.299 | ||
| EPS (TTM) (NT$) | -0.02 | ||
| Beta | 0.2933 | ||
| 3-Year Sharpe Ratio | -1.05 | ||
| 3-Year Sortino Ratio | -1.31 | ||
| Volatility % | 23.92 | ||
| 14-Day RSI | 56.32 | ||
| 14-Day ATR (NT$) | 0.428749 | ||
| 20-Day SMA (NT$) | 20.6725 | ||
| 12-1 Month Momentum % | -20.34 | ||
| 52-Week Range (NT$) | 20.1 - 29.15 | ||
| Shares Outstanding (Mil) | 60.55 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Abnova (Taiwan) Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Abnova (Taiwan) Corp Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| TWD 0.112000 Cash Dividend | 2026-06-16 | 20.80 (+0.97%) | ||
| TWD 0.900000 Cash Dividend | 2025-06-16 | 29.25 (-1.52%) | ||
| 1.03:1 Stock Split | 2017-08-28 | 34.71 (+0.99%) | ||
| 1.0128:1 Stock Split | 2016-08-26 | 33.02 (-0.14%) |
Show
Entries
Abnova (Taiwan) Corp Frequently Asked Questions
What is Abnova (Taiwan) Corp(TPE:4133)'s stock price today?
The current price of TPE:4133 is NT$21.20. The 52 week high of TPE:4133 is NT$29.15 and 52 week low is NT$20.10.
When is next earnings date of Abnova (Taiwan) Corp(TPE:4133)?
The next earnings date of Abnova (Taiwan) Corp(TPE:4133) is .
Does Abnova (Taiwan) Corp(TPE:4133) pay dividends? If so, how much?
The Dividend Yield %  of Abnova (Taiwan) Corp(TPE:4133) is 0.54% (As of Today), Highest Dividend Payout Ratio of Abnova (Taiwan) Corp(TPE:4133) was 1.46. The lowest was 0.16. And the median was 0.71. The  Forward Dividend Yield % of Abnova (Taiwan) Corp(TPE:4133) is 0.54%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Abnova (Taiwan) Corp
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers